Just reported
From Kenvue's results release of 30 octobre 2026; its quarterly report has since been filed.
Actual
3,89B $US
+3,2 % y/y
-1,7 % q/q
Guided
—
No guide given
Actual
0,22 $US
+4,8 % y/y
-8,3 % q/q
Guided
—
No guide given
Actual
706M $US
+12 % y/y
+1,0 % q/q
Guided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Les parts du chiffre d'affaires sont des estimations pour quarter ended 2026-09-27, pas des chiffres tirés d'un document officiel.
Tylenol
Nonprescription medicines for pain and fever.
Zyrtec
Medicines for allergy symptoms.
Nicorette
Products to help people stop smoking.
Neutrogena
Skin and hair care products, including face and body care.
Listerine
Mouthwash and other oral care products.
BAND-AID Brand
Adhesive bandages and other wound-care products.
Its brands include Tylenol and Zyrtec medicines, Neutrogena skin and hair care, Listerine mouthwash, and BAND-AID wound-care products. It sells through retail and online channels around the world. Kenvue has a pending agreement to combine with Kimberly-Clark, subject to remaining conditions and regulatory approvals.
Construit à partir des documents déposés par Kenvue Inc. auprès de la Securities and Exchange Commission (SEC), le gendarme boursier américain. Les chiffres sont tels que publiés, l’historique par action étant retraité sur la base d’actions d’aujourd’hui. Ceci décrit une entreprise — ce n’est pas un conseil en investissement ni une recommandation d’acheter ou de vendre.
The themes Kenvue is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
19,31 $US-1,3 %clôture 30 oct.
Chiffres jusqu’au 27 septembre 2026, issus du 10-Q déposé le 30 octobre 2026
Kenvue sells nonprescription medicines to shoppers through pharmacies and retailers, alongside skin care, mouthwash, baby care and wound-care products.
Grade C+
La bande sous le cours montre la note à chaque date, établie uniquement à partir des documents publics à ce moment-là.
Affichage de 2 trimestres sur 12 de l’historique des notes de Kenvue Inc.. Les 10 autres remontent jusqu’à mars 2024.